Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments

Press/Media

Period	24 Oct 2023

Media coverage

Title	Why the Relapsed/Refractory Acute Myeloid Leukemia Market is Expected to Witness Revolutionary Developments
Media name/outlet	UK Biotech Database
Country/Territory	Switzerland
Date	24/10/23
URL	ukbiotech.com/uk/portal/news_details.php?news_id=38009151k$SnhCSBJjkyz&page_id=?next=1
Persons	Mirna Chehade